These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21517807)

  • 1. Quantitative computed tomography assessment of transfusional iron overload.
    Wood JC; Mo A; Gera A; Koh M; Coates T; Gilsanz V
    Br J Haematol; 2011 Jun; 153(6):780-5. PubMed ID: 21517807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
    Rose C; Vandevenne P; Bourgeois E; Cambier N; Ernst O
    Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ouederni M; Ben Khaled M; Mellouli F; Ben Fraj E; Dhouib N; Yakoub IB; Abbes S; Mnif N; Bejaoui M
    Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.
    İdilman İS; Gümrük F; Haliloğlu M; Karçaaltıncaba M
    Turk J Haematol; 2016 Mar; 33(1):21-7. PubMed ID: 26376710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
    Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results.
    Wood JC; Zhang P; Rienhoff H; Abi-Saab W; Neufeld EJ
    Magn Reson Imaging; 2015 Jul; 33(6):761-7. PubMed ID: 25708262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
    Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
    Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients.
    Bacigalupo L; Paparo F; Zefiro D; Viberti CM; Cevasco L; Gianesin B; Pinto VM; Rollandi GA; Wood JC; Forni GL
    Radiol Med; 2016 Oct; 121(10):751-62. PubMed ID: 27334009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Energy CT for Patients Suspected of Having Liver Iron Overload: Can Virtual Iron Content Imaging Accurately Quantify Liver Iron Content?
    Luo XF; Xie XQ; Cheng S; Yang Y; Yan J; Zhang H; Chai WM; Schmidt B; Yan FH
    Radiology; 2015 Oct; 277(1):95-103. PubMed ID: 25880263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Lin H; Wei H; He N; Fu C; Cheng S; Shen J; Wang B; Yan X; Liu C; Yan F
    Eur Radiol; 2018 Aug; 28(8):3494-3504. PubMed ID: 29470640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of an R2* Method for Assessing Liver Iron Concentration (LIC) Against FerriScan: Derivation of the Calibration Curve and Characterization of the Nature and Source of Uncertainty in the Relationship.
    Jhaveri KS; Kannengiesser SAR; Ward R; Kuo K; Sussman MS
    J Magn Reson Imaging; 2019 May; 49(5):1467-1474. PubMed ID: 30291649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
    Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
    Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and mapping of liver iron concentrations using magnetic resonance imaging.
    St Pierre TG; Clark PR; Chua-Anusorn W
    Ann N Y Acad Sci; 2005; 1054():379-85. PubMed ID: 16339686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
    Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
    Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.